Model
Edge
Regeneron Pharmaceuticals, Inc.
REGN
Filing Type
10-K
Filing Date
2/3/2026
Updated
2/4/26, 7:08 AM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2024
EX-4.1
DESCRIPTION OF SECURITIES
EX-10.3 8
FORM OF STOCK OPTION AWARD AGREEMENT - EXECUTIVE OFFICERS
EX-10.3 9
FORM OF RESTRICTED STOCK AWARD AGREEMENT - EXECUTIVE OFFICERS
EX-10.3 10
FORM OF RSU AWARD AGREEMENT - NON-EMPLOYEE DIRECTORS
EX-21.1
SUBSIDIARIES OF THE REGISTRANT
EX-23.1
CONSENT OF PRICEWATERHOUSECOOPERS LLP
EX-31.1
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
GRAPHIC